Thynk Capital is a venture capital investment firm that invests in therapeutics, healthcare and technology companies. The firm focuses on early stage pharma and biotech developing treatment to Extend Healthy lifespan and address the major diseases of Aging including Alzheimer's, Dementia, Kidney Disease, Cancer, Diabetes, Frailty and Rare Disease.